Arcturus Therapeutics Holdings Inc (ARCT)

Deferred Revenue

$6.28M

Quarterly · Period ending: · USD

ARCT logo

ARCT Deferred Revenue

Latest reported$6.28M
ARCT Quarterly Deferred Revenue ($0.00 → $6.28M)
High-resolution chart · PNG

ARCT deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arcturus Therapeutics Holdings Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
6,276,000
7,610,000
8,246,000
7,212,000
13,684,000
15,092,000
21,935,000
28,972,000
44,876,000
74,509,000
47,343,000
44,260,000
51,956,000
46,569,000
36,116,000
10,552,000
26,349,000
53,062,000
43,482,000
57,616,000
18,071,000
17,936,000
0
0
0
0
0
10,999,000
9,730,000
7,728,000
6,272,000
8,451,000
11,168,000
0
6,457,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.